Umer Raffat
Stock Analyst at Evercore ISI
(4.23)
# 1,495
Out of 5,096 analysts
157
Total ratings
52.1%
Success rate
10.5%
Average return
Main Sectors:
Stocks Rated by Umer Raffat
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GILD Gilead Sciences | Reiterated: Buy | n/a | $170.33 | - | 17 | Oct 30, 2026 | |
| PBLS Parabilis Medicines | Reiterated: Buy | n/a | $27.25 | - | 2 | Oct 26, 2026 | |
| KOD Kodiak Sciences | Reiterated: Buy | n/a | $97.63 | - | 4 | Sep 28, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Hold | n/a | $1,410.99 | - | 15 | Sep 23, 2026 | |
| APMD Apnimed | Initiated Coverage: Buy | n/a | $15.40 | - | 1 | Aug 25, 2026 | |
| SYRE Spyre Therapeutics | Reiterated: Buy | n/a | $95.51 | - | 6 | Jun 3, 2026 | |
| PCVX Vaxcyte | Reiterated: Buy | n/a | $60.62 | - | 2 | May 21, 2026 | |
| BIIB Biogen | Initiated Coverage: Buy | n/a | $249.01 | - | 8 | May 15, 2026 | |
| KLRA Kailera Therapeutics | Initiated Coverage: Buy | n/a | $12.15 | - | 1 | May 12, 2026 | |
| ELAN Elanco Animal Health | Reiterated: Buy | n/a | $24.10 | - | 6 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $465.45 | - | 17 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $11.25 | - | 6 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $30.67 | - | 8 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $13.82 | - | 7 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.10 | +143.90% | 3 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $66.52 | - | 3 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $44.89 | - | 6 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.55 | - | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.85 | n/a | 6 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.9426 | n/a | 2 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.25 | n/a | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.29 | n/a | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $148.36 | n/a | 3 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $20.01 | n/a | 1 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $28.04 | n/a | 4 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $5.92 | n/a | 5 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $21.10 | n/a | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.67 | n/a | 6 | Dec 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $214.44 | n/a | 5 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $146.33 | n/a | 3 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.33 | n/a | 2 | Jun 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $25.30 | n/a | 1 | Mar 9, 2018 |
Gilead Sciences
Oct 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $170.33
Upside: -
Parabilis Medicines
Oct 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $27.25
Upside: -
Kodiak Sciences
Sep 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $97.63
Upside: -
Eli Lilly and Company
Sep 23, 2026
Reiterated: Hold
Price Target: n/a
Current: $1,410.99
Upside: -
Apnimed
Aug 25, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $15.40
Upside: -
Spyre Therapeutics
Jun 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $95.51
Upside: -
Vaxcyte
May 21, 2026
Reiterated: Buy
Price Target: n/a
Current: $60.62
Upside: -
Biogen
May 15, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $249.01
Upside: -
Kailera Therapeutics
May 12, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $12.15
Upside: -
Elanco Animal Health
May 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $24.10
Upside: -
May 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $465.45
Upside: -
Apr 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $11.25
Upside: -
Apr 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $30.67
Upside: -
Apr 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $13.82
Upside: -
Mar 9, 2026
Reiterated: Buy
Price Target: $10
Current: $4.10
Upside: +143.90%
Feb 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $66.52
Upside: -
Nov 12, 2025
Reiterated: Buy
Price Target: n/a
Current: $44.89
Upside: -
Nov 11, 2025
Reiterated: Buy
Price Target: n/a
Current: $15.55
Upside: -
Oct 8, 2025
Reiterated: Buy
Price Target: n/a
Current: $17.85
Upside: n/a
Sep 30, 2025
Reiterated: Buy
Price Target: n/a
Current: $0.9426
Upside: n/a
May 12, 2025
Reiterated: Buy
Price Target: n/a
Current: $19.25
Upside: n/a
Feb 21, 2025
Reiterated: Buy
Price Target: n/a
Current: $8.29
Upside: n/a
Feb 5, 2025
Reiterated: Buy
Price Target: n/a
Current: $148.36
Upside: n/a
Oct 15, 2024
Upgraded: Buy
Price Target: n/a
Current: $20.01
Upside: n/a
Mar 8, 2024
Downgraded: Hold
Price Target: n/a
Current: $28.04
Upside: n/a
May 11, 2023
Upgraded: Buy
Price Target: n/a
Current: $5.92
Upside: n/a
Nov 1, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $21.10
Upside: n/a
Dec 9, 2021
Reiterated: Buy
Price Target: n/a
Current: $18.67
Upside: n/a
Jan 28, 2021
Reiterated: Buy
Price Target: n/a
Current: $214.44
Upside: n/a
Jul 20, 2020
Reiterated: Buy
Price Target: n/a
Current: $146.33
Upside: n/a
Jun 4, 2019
Reiterated: Buy
Price Target: n/a
Current: $2.33
Upside: n/a
Mar 9, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $25.30
Upside: n/a